Brain GABA, dopamine and acetylcholine interactions. 1. Studies with oxotremorine.
D000109:Acetylcholine / Q000378:metabolism*; D000613:Aminobutyrates / Q000378:metabolism*; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001285:Atropine / Q000494:pharmacology; D001921:Brain / Q000378:metabolism*; D002421:Caudate Nucleus / Q000378:metabolism / Q000502:physiology; D002525:Cerebellar Cortex / Q000378:metabolism; D002540:Cerebral Cortex / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D007395:Interneurons / Q000502:physiology; D008297:Male; D008636:Mesencephalon / Q000378:metabolism; D009434:Neural Pathways / Q000502:physiology; D009714:Nucleus Accumbens / Q000378:metabolism; D009830:Olfactory Bulb / Q000378:metabolism; D010095:Oxotremorine / Q000494:pharmacology*; D051381:Rats; D011976:Receptors, Muscarinic / Q000502:physiology; D005680:gamma-Aminobutyric Acid / Q000378:metabolism*
D000613:Aminobutyrates; D011976:Receptors, Muscarinic; D005680:gamma-Aminobutyric Acid; D010095:Oxotremorine; D001285:Atropine; D001058:Apomorphine; D000109:Acetylcholine; D004298:Dopamine